Background: The bioavailability of g-tocopherol and metabolites of vitamin E after g-tocopherol administration is not well understood. We investigated the effect of g-tocopherol administration on the levels and metabolism of a-and g-tocopherol in healthy volunteers. Methods: We measured two metabolites of vitamin E (2,5,7,8-tetramethyl-2-(2 0 -carboxyethyl)-6-hydroxychroman (a-CEHC) and 2,7,8-trimethyl-2-(2 0 -carboxyethyl)-6-hydroxychroman (g-CEHC)) in plasma and urine by high-performance liquid chromatography with electrochemical detection (HPLC-ECD) during administration of g-tocopherol. Two groups of volunteers were enrolled. The g-tocopherol group received two g-tocopherol capsules (each containing 186.4 mg of g-tocopherol and 5 mg of a-tocopherol) for 28 days, while the control group received d-a-tocopherol at 5 mg/day, which was the same dose as that given to the g-tocopherol group. Blood and urine samples were obtained on days 0, 14, 28, 35, 42, and 56 after the initiation of g-tocopherol administration. Results: The plasma g-tocopherol concentration increased markedly during administration of g-tocopherol and the plasma g-CEHC concentration increased along with that of g-tocopherol. The plasma a-tocopherol concentration decreased significantly during g-tocopherol administration. The plasma concentration of a-CEHC decreased significantly and urinary excretion of a-CEHC tended to increase in the g-tocopherol group. Urinary sodium secretion was significantly increased at 1 week after the cessation of g-tocopherol administration, but there was no significant difference of urine volume between the two groups. Conclusion: Metabolism of a-tocopherol is accelerated and the plasma a-tocopherol concentration is decreased during g-tocopherol administration.